Yulin Feng
Research Subjects
Yulin Feng has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
Shilin Yang
Jiangxi Univ Tradit Chinese Med, Nanchang 330006, Jiangxi, Peoples R China
5 shared publications- Zhifeng Li
Jiangxi University of Traditional Chinese Medicine
4 shared publications - Dan Su
College of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China
3 shared publications Qi Wang
3 shared publications- Shilin Yang
College of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, 330004, China; Zhuang Yao Institute of traditional Chinese Medicine, Guangxi University of Chinese Medicine, Nanning, 530200, China; College of Pharmacy, Guangxi University of Chinese Medicine, Nanning, 530200, China; Guangxi Engineering Technology Research Center of Advantage Chinese Patent Drug and Ethnic Drug Development, Nanning, 530200, China
3 shared publications Xiao-Jian Luo
3 shared publications
Latest Publications
- Open Access
- 14 October 2019
- Published by MDPI AG in Metabolites
- Vol. 9 (10) , 227
Lomatogonium Rotatum for Treatment of Acute Liver Injury in Mice: A Metabolomics Study
Lomatogonium rotatum (L.) Fries ex Nym (LR) is used as a traditional Mongolian medicine to treat liver and bile diseases. This study aimed to investigate the hepatoprotective effect of LR on mice with CCl4-induced acute liver injury through conventional assays and metabolomics analysis. This study consisted of male mice (n = 23) in four groups (i.e., control, model, positive control, and LR). The extract of whole plant of LR was used to treat mice in the LR group. Biochemical and histological assays (i.e., serum levels of alanine transaminase (ALT) and aspartate transaminase (AST), and histological changes of liver tissue) were used to evaluate LR efficacy, and metabolomics analysis based on GC-MS and LC-MS was conducted to reveal metabolic changes. The conventional analysis and metabolomic profiles both suggested that LR treatment could protect mice against CCl4-induced acute liver injury. The affected metabolic pathways included linoleic acid metabolism, α-linolenic acid metabolism, arachidonic acid metabolism, CoA biosynthesis, glycerophospholipid metabolism, the TCA cycle, and purine metabolism. This study identified eight metabolites, including phosphopantothenic acid, succinic acid, AMP, choline, glycerol 3-phosphate, linoleic acid, arachidonic acid, and DHA, as potential biomarkers for evaluating hepatoprotective effect of LR. This metabolomics study may shed light on possible mechanisms of hepatoprotective effect of LR.
- 14 October 2019
- Published by MDPI AG in Metabolites
- Vol. 9 (10) , 227
Open AccessLomatogonium Rotatum for Treatment of Acute Liver Injury in Mice: A Metabolomics Study
Lomatogonium rotatum (L.) Fries ex Nym (LR) is used as a traditional Mongolian medicine to treat liver and bile diseases. This study aimed to investigate the hepatoprotective effect of LR on mice with CCl4-induced acute liver injury through conventional assays and metabolomics analysis. This study consisted of male mice (n = 23) in four groups (i.e., control, model, positive control, and LR). The extract of whole plant of LR was used to treat mice in the LR group. Biochemical and histological assays (i.e., serum levels of alanine transaminase (ALT) and aspartate transaminase (AST), and histological changes of liver tissue) were used to evaluate LR efficacy, and metabolomics analysis based on GC-MS and LC-MS was conducted to reveal metabolic changes. The conventional analysis and metabolomic profiles both suggested that LR treatment could protect mice against CCl4-induced acute liver injury. The affected metabolic pathways included linoleic acid metabolism, α-linolenic acid metabolism, arachidonic acid metabolism, CoA biosynthesis, glycerophospholipid metabolism, the TCA cycle, and purine metabolism. This study identified eight metabolites, including phosphopantothenic acid, succinic acid, AMP, choline, glycerol 3-phosphate, linoleic acid, arachidonic acid, and DHA, as potential biomarkers for evaluating hepatoprotective effect of LR. This metabolomics study may shed light on possible mechanisms of hepatoprotective effect of LR.
- 1 December 2018
- Published by Elsevier in Biochemical Systematics and Ecology
- Vol. 81, 80-82
Phytochemical and chemotaxonomic study on Loropetalum chinense (R. Br.) Oliv.
- 1 December 2018
- Published by Elsevier in Biochemical Systematics and Ecology
- Vol. 81, 80-82
Phytochemical and chemotaxonomic study on Loropetalum chinense (R. Br.) Oliv.
- Open Access
Isolation and Identification of the Anti-Oxidant Constituents from Loropetalum chinense (R. Brown) Oliv. Based on UHPLC–Q-TOF-MS/MS
The aim of this study was to identify the chemical constituents of Loropetalum chinense (R. Brown) Oliv. (LCO) and determine which of these had antioxidant effects. The chemical composition of a 70% ethanol extract of LCO was analyzed systematically using UHPLC–Q-TOF-MS/MS. The chemical components of the 70% ethanol extract of LCO were then separated and purified using macroporous resin and chromatographic techniques. Antioxidant activity was evaluated using a DPPH assay. In total, 100 compounds were identified tentatively, including 42 gallic acid tannins, 49 flavones, and 9 phenolic compounds. Of these, 7 gallium gallate, 4 flavonoid and 8 quinic acid compounds were separated and purified from the 70% ethanol extract of LCO. The compounds identified for the first time in LCO and in the genus Loropetalum were 3,4,5-trimethoxyphenyl-(6′-O-galloyl)-O-β-d-glucopyranoside, protocatechuic acid, ethyl gallate, 5-O-caffeoylquinic acid, 3-O-caffeoylquinic acid, 3,5-O-diocaffeoylquinic acid, 4,5-O-diocaffeoylquinic acid and 3,4-O-diocaffeoylquinic acid. The 50% inhibitory concentration (IC50) values of compounds 1,2,3,4,6-penta-O-galloyl-β-d-glucose, gallic acid, protocatechuic acid, and ethyl gallate were 1.88, 1.05, 1.18, and 1.05 μg/mL, respectively. Compared with the control group (VC) (2.08 μg/mL), these compounds exhibited stronger anti-oxidation activity. This study offered considerable insight into the chemical composition of LCO, with preliminary identification of the antioxidant ingredients.
Open AccessIsolation and Identification of the Anti-Oxidant Constituents from Loropetalum chinense (R. Brown) Oliv. Based on UHPLC–Q-TOF-MS/MS
The aim of this study was to identify the chemical constituents of Loropetalum chinense (R. Brown) Oliv. (LCO) and determine which of these had antioxidant effects. The chemical composition of a 70% ethanol extract of LCO was analyzed systematically using UHPLC–Q-TOF-MS/MS. The chemical components of the 70% ethanol extract of LCO were then separated and purified using macroporous resin and chromatographic techniques. Antioxidant activity was evaluated using a DPPH assay. In total, 100 compounds were identified tentatively, including 42 gallic acid tannins, 49 flavones, and 9 phenolic compounds. Of these, 7 gallium gallate, 4 flavonoid and 8 quinic acid compounds were separated and purified from the 70% ethanol extract of LCO. The compounds identified for the first time in LCO and in the genus Loropetalum were 3,4,5-trimethoxyphenyl-(6′-O-galloyl)-O-β-d-glucopyranoside, protocatechuic acid, ethyl gallate, 5-O-caffeoylquinic acid, 3-O-caffeoylquinic acid, 3,5-O-diocaffeoylquinic acid, 4,5-O-diocaffeoylquinic acid and 3,4-O-diocaffeoylquinic acid. The 50% inhibitory concentration (IC50) values of compounds 1,2,3,4,6-penta-O-galloyl-β-d-glucose, gallic acid, protocatechuic acid, and ethyl gallate were 1.88, 1.05, 1.18, and 1.05 μg/mL, respectively. Compared with the control group (VC) (2.08 μg/mL), these compounds exhibited stronger anti-oxidation activity. This study offered considerable insight into the chemical composition of LCO, with preliminary identification of the antioxidant ingredients.
- 1 December 2017
- Published by Elsevier in Phytochemistry Letters
- Vol. 22, 92-94
New compounds with anti-inflammatory potential from Disporum cantoniense
- 1 December 2017
- Published by Elsevier in Phytochemistry Letters
- Vol. 22, 92-94
New compounds with anti-inflammatory potential from Disporum cantoniense
- 1 July 2016
- Published by Elsevier in Fitoterapia
- Vol. 112, 45-55
New metabolites of acteoside identified by ultra-performance liquid chromatography/quadrupole-time-of-flight MSE in rat plasma, urine, and feces
- 1 July 2016
- Published by Elsevier in Fitoterapia
- Vol. 112, 45-55
New metabolites of acteoside identified by ultra-performance liquid chromatography/quadrupole-time-of-flight MSE in rat plasma, urine, and feces
- 1 March 2016
- Published by Elsevier in Phytochemistry Letters
- Vol. 15, 94-97
New compounds with neuroprotective activities from Gastrodia elata
- 1 March 2016
- Published by Elsevier in Phytochemistry Letters
- Vol. 15, 94-97
New compounds with neuroprotective activities from Gastrodia elata
- 27 May 2015
- Published by Wiley in Biomedical Chromatography
- Vol. 29 (12) , 1885-1892
Comparative pharmacokinetic profiles of five poorly soluble pulchinenosides in different formulations from Pulsatilla chinensis saponins extracts for enhanced bioavailability
Pulsatilla chinensis, a traditional Chinese medicine (TCM), has been used for treating amoebic diseases, vaginal trichomoniasis and bacterial infections over a long history. Now growing attention has been attracted to its antitumor activities. The purpose of this work was to compare the pharmacokinetic profiles of pulchinenosides in different formulations and to improve their oral bioavailability. Extracts of P. chinensis saponins were prepared for PRS‐Na (salt forming), PRS‐HPβCD (hydroxypropyl‐β‐cyclodextrin inclusion complex), PRS‐O/W (oil‐in‐water emulsion) and PRS‐silica (micronization), respectively. A simpler and more durable LC‐MS/MS method was developed in this study for quantitative analysis of pulsatilla sapoin D, B7, B10, B11 and sapoin PD simultaneously. The four formulations enhanced saponins oral bioavailability to varying degrees, as PRS‐HPβCD > PRS‐silica > PRS‐O/W > PRS‐Na, which indicated that water‐soluble preparations can obviously improve the solubility of saponins, and are helpful to increase bioavailability. In particular, hydroxypropyl‐β‐cyclodextrin inclusion complex was the most effective way to promote absorption of saponins, raising the F values (bioavailability) >20 times. Therefore, P. chinensis saponin molecules can be slowly released by emulsion and micronization, which can avoid the enormous Cmax appearing in HPβCD, considering the pharmacokinetics profiles. However, appropriate pharmacokinetic parameters were observed in PRS‐Na, although the F value was minimum among the four preparations. Copyright © 2015 John Wiley & Sons, Ltd.
- 27 May 2015
- Published by Wiley in Biomedical Chromatography
- Vol. 29 (12) , 1885-1892
Comparative pharmacokinetic profiles of five poorly soluble pulchinenosides in different formulations from Pulsatilla chinensis saponins extracts for enhanced bioavailability
Pulsatilla chinensis, a traditional Chinese medicine (TCM), has been used for treating amoebic diseases, vaginal trichomoniasis and bacterial infections over a long history. Now growing attention has been attracted to its antitumor activities. The purpose of this work was to compare the pharmacokinetic profiles of pulchinenosides in different formulations and to improve their oral bioavailability. Extracts of P. chinensis saponins were prepared for PRS‐Na (salt forming), PRS‐HPβCD (hydroxypropyl‐β‐cyclodextrin inclusion complex), PRS‐O/W (oil‐in‐water emulsion) and PRS‐silica (micronization), respectively. A simpler and more durable LC‐MS/MS method was developed in this study for quantitative analysis of pulsatilla sapoin D, B7, B10, B11 and sapoin PD simultaneously. The four formulations enhanced saponins oral bioavailability to varying degrees, as PRS‐HPβCD > PRS‐silica > PRS‐O/W > PRS‐Na, which indicated that water‐soluble preparations can obviously improve the solubility of saponins, and are helpful to increase bioavailability. In particular, hydroxypropyl‐β‐cyclodextrin inclusion complex was the most effective way to promote absorption of saponins, raising the F values (bioavailability) >20 times. Therefore, P. chinensis saponin molecules can be slowly released by emulsion and micronization, which can avoid the enormous Cmax appearing in HPβCD, considering the pharmacokinetics profiles. However, appropriate pharmacokinetic parameters were observed in PRS‐Na, although the F value was minimum among the four preparations. Copyright © 2015 John Wiley & Sons, Ltd.
- 1 January 2015
- Published by Springer Nature in Chemistry of Natural Compounds
- Vol. 51 (1) , 108-110
A New Nortriterpenoid Saponin from the Fruit of Akebia trifoliata
- 1 January 2015
- Published by Springer Nature in Chemistry of Natural Compounds
- Vol. 51 (1) , 108-110
A New Nortriterpenoid Saponin from the Fruit of Akebia trifoliata
- 1 December 2014
- Published by Elsevier in Fitoterapia
- Vol. 99, 139-152
Comparative pharmacokinetics and tissue distribution study of mono-, and di-caffeoylquinic acids isomers of Ainsliaea fragrans Champ by a fast UHPLC–MS/MS method
- 1 December 2014
- Published by Elsevier in Fitoterapia
- Vol. 99, 139-152
Comparative pharmacokinetics and tissue distribution study of mono-, and di-caffeoylquinic acids isomers of Ainsliaea fragrans Champ by a fast UHPLC–MS/MS method
- 1 May 2014
- Vol. 39 (9) , 1593-6
[Determination of equilibrium solubility and n-octanol/water partition coefficient of pulchinenosiden D by HPLC].
To determine the equilibrium solubility of pulchinenosiden D in different solvents and its n-octanol/water partition coefficients. Combining shaking flask method and high performance liquid chromatography (HPLC) to detect the n-octanol/water partition coefficients of pulchinenosiden D, the equilibrium solubility of pulchinenosiden D in six organic solvents and different pH buffer solution were determined by HPLC analysis. n-Octanol/water partition coefficients of pulchinenosiden D in different pH were greater than zero, the equilibrium solubility of pulchinenosiden D was increased with increase the pH of the buffer solution. The maximum equilibrium solubility of pulchinenosiden D was 255.89 g x L(-1) in methanol, and minimum equilibrium solubility of pulchinenosiden D was 0.20 g x L(-1) in acetonitrile. Under gastrointestinal physiological conditions, pulchinenosiden D exists in molecular state and it has good absorption but poor water-solubility, so increasing the dissolution rate of pulchinenosiden D may enhance its bioavailability.
- 1 May 2014
- Vol. 39 (9) , 1593-6
[Determination of equilibrium solubility and n-octanol/water partition coefficient of pulchinenosiden D by HPLC].
To determine the equilibrium solubility of pulchinenosiden D in different solvents and its n-octanol/water partition coefficients. Combining shaking flask method and high performance liquid chromatography (HPLC) to detect the n-octanol/water partition coefficients of pulchinenosiden D, the equilibrium solubility of pulchinenosiden D in six organic solvents and different pH buffer solution were determined by HPLC analysis. n-Octanol/water partition coefficients of pulchinenosiden D in different pH were greater than zero, the equilibrium solubility of pulchinenosiden D was increased with increase the pH of the buffer solution. The maximum equilibrium solubility of pulchinenosiden D was 255.89 g x L(-1) in methanol, and minimum equilibrium solubility of pulchinenosiden D was 0.20 g x L(-1) in acetonitrile. Under gastrointestinal physiological conditions, pulchinenosiden D exists in molecular state and it has good absorption but poor water-solubility, so increasing the dissolution rate of pulchinenosiden D may enhance its bioavailability.